drugset / Trial / NCT01737216
Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
Pilot study of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer. The purpose is to assess the effects of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer on bone mineral density gain in the lumbar spine and total hip.
Timeline
- Start
- 2012-11
- Primary completion
- 2016-01
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 4 mg | — |
| Comparator | DDP | Unknown | 60 mg/m2 | — |
| Comparator | DDP | Unknown | 75 mg/m2 | — |
| Comparator | Etoposide | Small molecule | 100 mg/m2 | — |
| Comparator | PTX | Unknown | 135 mg/m2 | — |
| Comparator | PTX | Unknown | 175 mg/m2 | — |